|
05 Dec 2007 |
Genentech Provides Update From Avastin FDA Advisory Meeting
|
|
05 Dec 2007 |
Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
|
|
04 Dec 2007 |
Centocor and Janssen-Cilag Submit Appplications Requesting Approval of Ustekinumab in the U.S. and Europe For Treatment of Moderate to Severe Plaque Psoriasis
|
|
04 Dec 2007 |
Arana Announces Phase II Trials For Lead Compound ART621
|
|
04 Dec 2007 |
Eisai and BioArctic Neuroscience Enter Exclusive Licensing Agreement
|
|
04 Dec 2007 |
Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
|
|
04 Dec 2007 |
Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
|
|
03 Dec 2007 |
"Actemra(R)," a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody, Filed for Rheumatoid Arthritis in Europe
|
|
02 Dec 2007 |
Novartis further strengthens biologics capabilities in expansion of MorphoSys collaboration
|
|
29 Nov 2007 |
New Data Highlight That Treatment With Erbitux Allows More Resections of Preteated Patients With Metastatic Colorectal Cancer
|
|
29 Nov 2007 |
Regeneron Initiates Major Global Collaboration with Sanofi-aventis to Develop and Commercialize Fully-Human Therapeutic Antibodies
|
|
28 Nov 2007 |
MediGene and Celltrion Announce Co-development of Anti-L1 Monoclonal Antibody Therapeutic for Treating Cancer
|
|
26 Nov 2007 |
MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
|
|
21 Nov 2007 |
Roche Submits Application for FDA Approval of Actemra for the Treatment of Rheumatoid Arthritis
|
|
21 Nov 2007 |
Kyto Biopharma Inc. Confirms Definitive Isolation of the Human Vitamin B12 Receptor (TCblR)
|
|
20 Nov 2007 |
Genmab and Glaxosmithkline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
|
|
20 Nov 2007 |
Biogen Idec and Neurimmune Therapeutics Announce Alliance to Develop Treatments for Alzheimer's Disease
|
|
19 Nov 2007 |
Avastin Shows Encouraging Results in Phase II Study in Patients With the Most Aggressive Form of Brain Cancer
|
|
19 Nov 2007 |
Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
|
|
16 Nov 2007 |
CHMP Adopts Negative Opinion on Appeal on European Application For natalizumab for the Treatment of Crohn's Disease
|
|
16 Nov 2007 |
Avastin receives positive opinion in Europe for first-line treatment of patients with advanced kidney cancer
|
|
16 Nov 2007 |
UCB to Appeal European Negative Opinion on CIMZIA(R) for the Treatment of Patients with Crohn's Disease
|
|
16 Nov 2007 |
Abbott's HUMIRA(R) Receives Positive Opinion from EMEA for Treatment of Moderate to Severe Plaque Psoriasis
|
|
14 Nov 2007 |
ThromboGenics Begins Preclinical Development of Anti-VPAC Antibody for Thrombocytopenia
|
|
14 Nov 2007 |
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
|
